Clinical Trials Browser

Phase 2 × Central Nervous System Neoplasms × Endocrine × Clear all

Neoplasms, Germ Cell and Embryonal, Ovarian Neoplasms, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Carcinoma, Neuroendocrine, Lymphoma, Extranodal NK-T-Cell

NCT00616642 2020-08-14

Rosiglitazone in Treating Patients With Pituitary Tumors

Phase 2 Terminated

1 enrolled 4 charts

CNSEndocrine

Pituitary Neoplasms, Central Nervous System Neoplasms

NCT00601289 2020-07-31

Temozolomide in Treating Patients With Invasive Pituitary Tumors

Phase 2 Withdrawn

CNSEndocrine

Adenoma, Basophil, Adenoma, Chromophobe, Adenoma, Acidophil, Pituitary Neoplasms, Prolactinoma, Central Nervous System Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

Clinical Trials

AcSé

Rosiglitazone in Treating Patients With Pituitary Tumors

Temozolomide in Treating Patients With Invasive Pituitary Tumors